Artwork

Content provided by Jayanth Sridhar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jayanth Sridhar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 423: Angiogenesis 2024 Recap with Dr. Philip Rosenfeld Including Discussion of Imaging for AMD, Geographic Atrophy Treatment Benefits and Risks, and More

 
Share
 

Manage episode 406067065 series 1424443
Content provided by Jayanth Sridhar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jayanth Sridhar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Dr. Philip Rosenfeld joins to discuss the Angiogenesis 2024 meeting, with topics covered including imaging breakthroughs for age-related macular degeneration, geographic atrophy treatment benefits and risks, and the importance of molarity in assessing efficacy and safety of intravitreal agents.

Relevant Financial Disclosures: Dr. Rosenfeld has consulted for Regeneron and Zeiss. Dr. Sridhar has consulted for Apellis, Genentech, Iveric, and Regeneron.

You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

  continue reading

301 episodes

Artwork
iconShare
 
Manage episode 406067065 series 1424443
Content provided by Jayanth Sridhar. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jayanth Sridhar or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Dr. Philip Rosenfeld joins to discuss the Angiogenesis 2024 meeting, with topics covered including imaging breakthroughs for age-related macular degeneration, geographic atrophy treatment benefits and risks, and the importance of molarity in assessing efficacy and safety of intravitreal agents.

Relevant Financial Disclosures: Dr. Rosenfeld has consulted for Regeneron and Zeiss. Dr. Sridhar has consulted for Apellis, Genentech, Iveric, and Regeneron.

You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

  continue reading

301 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide